• Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
  Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
• Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
• Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
• Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
• Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
• Solid team management skills, as well as Customer Service relationship and management
• Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

Matthew Leets is an attorney and customs broker with over a decade of experience in pharmaceutical supply chains principally in and adjacent to global trade compliance for pre-commercial activity.

Tony is currently Associate Director, Clinical Supply Lead, at Alexion Pharmaceuticals, Inc. He joined the global clinical supply team in 2022
and has been supporting several late phase programs, including supply planning, vendor management and global distribution to support rare
disease patients in over 100 countries.

Prior to Alexion, he worked for Charles River Labs for five years as a Sr. Manager, Global Categories, leading category strategies, strategic
projects, Supply Chain analytics, contract negotiations and SRM & KPI Metrics. In addition, he led logistics planning for kidney care division at Fresenius. He redesigned the direct to patient delivery model and managed the RFP projects for both linehaul and last mile freight. In the
first 10 years of his career, he had various Operations roles at Trelleborg and Sinochem, both in Asia and the Greater Boston area.

He studied Supply Chain Management at MIT and is Lean Sigma Certified through Purdue University and ‘Certified Supply Chain
Professional’ (CSCP) through APICS. In his spare time, he volunteers for CSCMP as VP of Programs of the New England Roundtable.

Tomasz Adamusiak, MD PhD, serves as the Chief Scientist for Clinical Quality and Data Science at MITRE, where he leads initiatives to improve healthcare outcomes through AI and real-world evidence. Previously, as Head of Data Science at the Pfizer Innovation Research Lab, he led work on digital endpoints and decentralized clinical trials. He has held leadership positions within the American Medical Informatics Association and SNOMED International, and has published extensively in peer-reviewed journals.

Research Assistant Professor at Tufts University School of Medicine and Director of Sponsored Projects at Tufts CSDD.
Expertise in benchmarking drug development operating practices.
Research focus includes outsourcing and partnerships; clinical supplies; investigative site initiation and management; patient recruitment and retention; and the use of technologies and digital solutions in clinical trials.
Published extensively and is a frequent speaker at global conferences.
Current Initiatives Include:
• Study volunteer diversity in clinical trials
• Benchmarking patient recruitment and retention practices
• Industry use of automation, IT technologies and applications

Maria is a Senior Consultant at the Tufts Center for the Study of Drug Development at Tufts University School of Medicine, where she focuses on pharmaceutical regulatory policy, technology adoption and digital transformation in the biopharmaceutical sector, and operational efficiency across the drug development lifecycle—from idea to patient.

Her work has been published in leading health policy and medical journals, including JAMA Network Open, Nature Communications, Therapeutic Innovation & Regulatory Science, and Clinical Pharmacology & Therapeutics. She speaks regularly at domestic and international conferences and serves as a peer reviewer for several journals including npj Digital Medicine, Contemporary Clinical Trials, Scientific Reports, BMC Clinical Research Methodology, and Health Research Policy and Systems.

Previously, Maria held advisory and strategy roles at NewYork-Presbyterian (Weill Cornell Medicine and Columbia University College of Physicians and Surgeons), Cleveland Clinic Innovations, and served on the management team of Shield Biotech, an early-stage cancer immunotherapy company and Cleveland Clinic spinoff.

Maria holds a bachelor’s degree with honors in economics from Stony Brook University and a Master of Arts in Law and Diplomacy (MALD), with a concentration in international economics, from The Fletcher School of Law and Diplomacy at Tufts University.

Leticia has over 23 years of industry experience managing several research projects and clinical studies in various roles. She started her career in Pharma at Biogen, working collaboratively in an integrated monoclonal antibody research team and then moving to development in clinical operations, where she managed numerous phase I-III clinical trials in diverse therapeutic areas including, gastroenterology, immunology, neurology, and neuropathic pain.

She continued her career at Merck/EMD Serono where she provided strategic and operational expertise in the planning and conduct of several Phase I-III clinical studies in oncology and immuno-oncology, which led to the FDA accelerated approval of BAVENCIO® in merkel cell carcinoma and in urothelial carcinoma. Later she served as a Chief of Staff to the Sr. VP and Head of Development in Oncology, where she partnered with executive sponsors to identify and promote projects that are of strategic importance to the company and translating the function strategy into operational plans.
After many years in big Pharma, Leticia continued her career at various biotech companies: first at Kiniksa Pharmaceuticals, where she was responsible for various programs with high complexity in rare diseases, consisting of numerous global clinical trials in 10 different indications. Followed by Black Diamond Therapeutics, a biotech company addressing the significant unmet need for novel precision oncology therapies for patients with genetically defined cancers. In her last role, Leticia served as the Clinical Operations Lead at Nimbus Therapeutics, a biotech company working on the development of a HPK1 inhibitor in solid tumors.

Leticia also serves as an IRB Member at Yale University and is the Chair and President of the Association of Clinical Research Professionals (ACRP) - New England Chapter.
Leticia earned her Bachelor’s Degree in Biomedical Laboratory and Clinical Sciences from the School of Medicine at Boston University, followed by a Master’s Degree in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston.

Kerri Raso holds a MS in Clinical Investigation and has worked as a Clinical Systems Expert for over 25 years with positions ranging from system design consultant, IT manager, project/program manager and vendor manager. She has worked at both software vendors and on the sponsor side for large and very small biotech companies, spanning a wide array of therapeutic areas including rare disease and oncology. Over the last 15 years, her main passion has been IRT and IRT-integrated technologies such as drug forecasting, eConsent, eCOA and other clinical devices & wearables.  Kerri is currently Director, IRT Systems overseeing IRT, eCOA and Central Imaging at Tango Therapeutics.

Sunny Li is Associate Director, Global Clinical Supply Chain Planning at Takeda. She has 20 years of supply chain experience and specializes in end-to-end clinical supply planning, scenario analysis, and risk mitigation for complex development programs. Her background spans global clinical supply, new product introduction, and operational planning across multiple industries.

With over 10 years of pharmaceutical experience, Benjy Etienne is a proven clinical supply leader who has delivered more than $500M in cost savings through strategic comparator sourcing and vendor optimization. He brings strong cross-functional leadership, partnering effectively across Clinical Operations, CMC, Quality, and Finance to drive efficient, reliable clinical supply outcomes.

Dr Hitscherich has been working in industry for over 25 years. He is currently the Head External Operations at Alnylam Pharmaceuticals. Prior to joining Alnylam he had positions at Biogen, Bristol Myers and Wyeth. He has participated in the development and commercialization of numerous parenteral products. Dr Hitscherich received his BS in Chemical Engineering from Penn State University, MBA from Northeastern University, and his PhD in Biochemical Engineering from the University of Iowa.

Tom has worked in the life sciences industry since 1997, with the first 10 years spent as a pharmaceutical representative and marketing product manager for Bertek, Merck and GSK.

Tom joined Valeris in 2008, created the RxStudy Card offering in 2009 and since then has been focused on changing the paradigm of the traditional clinical trial supply process to one of greater efficiency.

• Work in Pharmaceutical Logistics since 2003
• Management of lots of change and new technologies in the last 20+ years
• Work history in small and large logistics companies, medical device manufacturing, vaccine manufacturing, and in the gene therapy field
• Dangerous goods expertise, logistics & supply chain management of multiple clinical trials, depth of knowledge of the pharmaceutical cold chain

Dan is the Director of Business Development for the US at N-SIDE, where he has spent the past four years helping biopharma companies improve how they plan and forecast their clinical supply chains. He works closely with clinical leaders to bring practical, data-driven strategies to planning both simple & complex trial portfolios. Dan focuses on building the right partnerships, ensuring N-SIDE works with innovative organizations where its expertise can deliver meaningful impact.

Max is passionate about problem solving and change management. He leads the Solutions Engineering team and has been at N-SIDE for over 8 years. He helps pharmaceutical organizations realize the value of optimization and transform their forecasting & planning processes.

Sebastian Tomlin is a senior supply chain and logistics leader in the life sciences sector, with more than 16 years of experience supporting organizations from early‑stage biotech to global pharmaceutical companies. He currently serves as Director of Distribution and Logistics at Cullinan Therapeutics, where he’s built scalable global supply chain systems supporting multiple functions. Previously, he founded and led Charles River’s global Specialist Logistics Services group and oversaw nationwide operations at Biocair which included support with global operations development. Sebastian has a BSc in Forensic Science and a variety of Supply Chain industry relevant certifications, including a certification in AI‑driven supply chain management through MIT, is an active industry speaker and community leader focused on advancing intelligent, resilient supply chains that ultimately help improve patients lives.

Chris brings over 25 years of leadership experience in supply chain, operations, procurement, sourcing, contracting, logistics, and alliance collaboration as both a practitioner as well as in an advisory role primarily in the life sciences industry.

Chris currently leads supply chain operations for Upstream Bio and is responsible for establishing supply chain readiness for commercialization of the company’s first product. Prior to Upstream Bio, Chris was the Managing Director of Petilliam Group, a boutique supply chain consultancy advising life sciences companies in all aspects of clinical and commercial supply chain development. Chris also has held various leadership roles at Akebia Therapeutics, Synageva, Alkermes, Transkaryotic Therapies, and Ares Serono.

Chris served on the Board of Directors of the Institute of Supply Management Pharmaceutical Forum for nearly a decade and has shared his experience as a speaker at various local, regional, and international events. He holds an MBA from Boston University and BS from Suffolk University as well as CPSM and Lifetime C.P.M. certification from the Institute of Supply Management, CPIM certification from the Association for Supply Chain Management, and completed executive education programs at Tuck Business School of Dartmouth and MIT Sloan School of Management.  

Over 20 years of experience in successfully building supply chain and quality organizations from the ground up, developing systems, procedures, & solid collaborative teams that successfully brought clinical trials to product commercialization. Deep expertise in end-to-end supply chain, quality assurance (QA), quality control (QC), chemistry manufacturing controls (CMC), streamlining systems & infrastructure, supplier relationship management (SRM), and building/leading high-performing teams.  Deirdre's career includes leading teams and working in growing organizations including Biogen, Millennium, Shire, & Alnylam.

Rachael Pirrami went to school at the University of Toledo in Ohio where she got her B.S in Pharmaceutical Sciences, MBA, and PharmD. She worked as a Procurement and Logistics Pharmacy Intern at the Cleveland Clinic for 3 years and is now training as a Global Clinical Supply Chain Fellow at Takeda Pharmaceuticals. As a Fellow, she gets experience in all the various clinical supply chain areas including planning, operations, digital excellence, import and export, comparators and ancillaries, and vendor management.

Chris is Co-Founder and CTO of Bluefin. Prior to founding Bluefin, he worked as a software engineer at MIT Lincoln Laboratory, specializing in counter-weapons of mass destruction simulations. Chris holds a B.S. and M.S. from Rensselaer Polytechnic Institute (RPI).

Investigator with community health focused research . Pursuing therapeutic innovation and  seamlessly connecting scientific discoveries in healthcare advancements.

I am a Supply Chain Lead in Pfizer’s Global Clinical Supply organization, where I support the planning and execution of clinical trial supply. Over the past 10 years, I’ve worked across clinical supplies in multiple pharmaceutical companies, building a well-rounded understanding of end-to-end trial supply chain operations. In my current role, I partner closely with cross-functional teams across departments and divisions to anticipate trial needs, solve day-to-day challenges, and help ensure patients and sites receive the right materials at the right time.